Cost–Benefit and Cost–Utility Analysis of Amphotericin B Supplementation of Corneal Storage Media With Endothelial Keratoplasty-Prepared Tissue

Cost-benefit analysis can be used to quantify the value of clinical pharmacy services. Providing Effective Therapy and Minimum cost, Quantify costs of care, Quantify outcomes, Assess whether and by how much average costs and outcomes differ among treatment groups, Compare magnitude of difference in costs and outcomes and evaluate “value for costs” by reporting a cost-effectiveness ratio, net monetary benefit, or probability that ratio is acceptable – Potential hypothesis: Cost per quality-adjusted life year saved significantly less than Rs.75,000, To Perform sensitivity analysis. For providing good effective therapy with less adverse drug reaction at affordable price, Cost-Identification, Cost-Effectiveness Analysis, Cost-Utility Analysis, Cost-Benefit Analysis, Clinical outcomes: Cure, comfort and survival, Humanistic outcomes: Physical, emotional, social function, role performance, Economic outcomes, Economic Evaluation, Cost of Illness Evaluation (COI), Cost Benefit Analysis (CBA), Cost Minimization Analysis, Cost Effective Analysis: Cost Utility Analysis.

Download Full-text

Acquisition of a Dose Management System with Consideration of Medico-Legal and Economic Aspects

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ◽

10.1055/a-1710-3529 ◽

2021 ◽

Author(s):

Thuy Duong Do ◽

Claudius Melzig ◽

Hans-Ulrich Kauczor ◽

Marc-André Weber ◽

Mark Oliver Wielpütz

Keyword(s):

Cost Benefit Analysis ◽

Cost Benefit ◽

Steering Committee ◽

Cost Utility ◽

Cost Utility Analysis ◽

Current Status ◽

Actual Condition ◽

Utility Analysis ◽

Advantages And Disadvantages ◽

Dose Management

Background New radiation protection regulation encompassing additional obligations for monitoring, reporting and recording of radiation exposure, was enacted on December 31, 2018. As a consequence, dose management systems (DMS) are necessary to fulfill the requirements. The process of selection, acquisition and implementation of a suitable IT solution for this purpose is a challenge that all X-ray-applying facilities, including hospitals and private practices, are currently facing. Method A target/actual-analysis as well as a cost-utility analysis is presented for this specific case as a foundation for the acquisition decision-making process. Result An actual analysis is necessary in order to record the current status of dose documentation. An interdivisional approach is recommended to include all imaging modalities and devices. An interdisciplinary steering committee can be helpful in enabling consensus and rapid action. A target analysis includes additional criteria with respect to ease of operation, technical feasibility, process optimization and research opportunities to consider in addition to the statutory requirements. By means of a cost-benefit analysis, considerations between costs and the individually weighted advantages and disadvantages of eligible DMS result in a ranking of preference for the available solutions. Conclusion Requirements of a DMS can be summarized in a specification sheet. Deploying an actual condition analysis, target state analysis and cost-utility analysis can help to identify a suitable DMS to achieve rapid commissioning and highest possible user acceptance while optimizing costs at the same time. Key Points: Citation Format

Download Full-text

Chapter 13: Cost-Effectiveness Analysis, Cost-Utility Analysis, and Cost-Benefit Analysis

Understanding Health Outcomes and Pharmacoeconomics ◽

10.21019/9781582122823.ch13 ◽

2017 ◽

Author(s):

Junhua Yu ◽

Jaewhan Kim

Keyword(s):

Cost Effectiveness ◽

Cost Benefit Analysis ◽

Cost Benefit ◽

Cost Utility ◽

Cost Effectiveness Analysis ◽

Cost Utility Analysis ◽

Benefit Analysis ◽

Utility Analysis ◽

Effectiveness Analysis

Download Full-text

Not Only Clinical Efficacy in Psychological Treatments: Clinical Psychology Must Promote Cost-Benefit, Cost-Effectiveness, and Cost-Utility Analysis

Frontiers in Psychology ◽

10.3389/fpsyg.2016.00563 ◽

2016 ◽

Vol 7 ◽

Cited By ~ 10

Author(s):

Gianluca Castelnuovo ◽

Giada Pietrabissa ◽

Roberto Cattivelli ◽

Gian Mauro Manzoni ◽

Enrico Molinari

Keyword(s):

Cost Effectiveness ◽

Clinical Efficacy ◽

Clinical Psychology ◽

Cost Benefit ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Psychological Treatments ◽

Benefit Cost

Download Full-text

Cost-utility in CNS drug trials

European Psychiatry ◽

10.1016/0924-9338(96)85183-2 ◽

1996 ◽

Vol 11 (3) ◽

pp. 159-164

Author(s):

F Ziegler

Keyword(s):

Clinical Trials ◽

Standard Gamble ◽

Cost Benefit ◽

Cost Utility ◽

Cost Utility Analysis ◽

Drug Trials ◽

Utility Analysis ◽

Theoretical Level ◽

Health States

SummaryThis paper considers some of the theoretical and practical problems of conducting cost-utility analyses alongside clinical trials. In order to measure utilities of different health states in a clinical trial a number of critical assumptions have to be made. Some of these assumptions are questionable on a theoretical level, others empirically invalid. The practical problems of measuring utilities are discussed. The standard gamble is shown to be the most validated method of utility measurement, but still based on very strong assumptions. The standard gamble instrument is also costly and difficult to administer in clinical trials. Other instruments are found to be less valid than the standard gamble. It is concluded that although cost-utility analysis seems relevant in some instances, investigators should avoid this assessment of utility and instead measure cost-effectiveness, cost-benefit and quality of life.

Download Full-text